Jonathan Young - Net Worth and Insider Trading
Jonathan Young Net Worth
The estimated net worth of Jonathan Young is at least $11 Million dollars as of 2025-04-29. Jonathan Young is the COO of Akero Therapeutics Inc and owns about 260,540 shares of Akero Therapeutics Inc (AKRO) stock worth over $11 Million. Details can be seen in Jonathan Young's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jonathan Young has not made any transactions after 2025-03-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jonathan Young
Jonathan Young Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan Young owns 1 companies in total, including Akero Therapeutics Inc (AKRO) .
Click here to see the complete history of Jonathan Young’s form 4 insider trades.
Insider Ownership Summary of Jonathan Young
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| AKRO | Akero Therapeutics Inc | 2025-03-12 | Chief Operating Officer |
Jonathan Young Latest Holdings Summary
Jonathan Young currently owns a total of 1 stock. Jonathan Young owns 260,540 shares of Akero Therapeutics Inc (AKRO) as of March 12, 2025, with a value of $11 Million.
Latest Holdings of Jonathan Young
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKRO | Akero Therapeutics Inc | 2025-03-12 | 260,540 | 42.17 | 10,986,972 |
Holding Weightings of Jonathan Young
Jonathan Young Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan Young has made a total of 33 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years, including 0 buys and 33 sells. The most-recent trade in Akero Therapeutics Inc is the sale of 607 shares on March 12, 2025, which brought Jonathan Young around $27,242.
Insider Trading History of Jonathan Young
- 1
Jonathan Young Trading Performance
Jonathan Young Ownership Network
Ownership Network List of Jonathan Young
Ownership Network Relation of Jonathan Young
Jonathan Young Owned Company Details
What does Akero Therapeutics Inc do?
Who are the key executives at Akero Therapeutics Inc?
Jonathan Young is the Chief Operating Officer of Akero Therapeutics Inc. Other key executives at Akero Therapeutics Inc include Chief Scientific Officer Timothy Rolph , Chief Development Officer Catriona Yale , and director & President & CEO Andrew Cheng .
Akero Therapeutics Inc (AKRO) Insider Trades Summary
Over the past 18 months, Jonathan Young made 21 insider transaction in Akero Therapeutics Inc (AKRO) with a net sale of 253,518. Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 258,578 shares made by Catriona Yale , a net sale of 469,800 shares made by Andrew Cheng , and a net sale of 75,684 shares made by Timothy Rolph .
In summary, during the past 3 months, insiders sold 215,474 shares of Akero Therapeutics Inc (AKRO) in total and bought 400,000 shares, with a net purchase of 184,526 shares. During the past 18 months, 1,369,372 shares of Akero Therapeutics Inc (AKRO) were sold and 600,000 shares were bought by its insiders, resulting in a net sale of 769,372 shares.
Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akero Therapeutics Inc Insider Transactions
Jonathan Young Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan Young. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jonathan Young's mailing address is: South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
